Effect of advanced glycation end-products on gene expression and synthesis of TNF-α and endothelial nitric oxide synthase by endothelial cells

This publication has 40 references indexed in Scilit:

• Tumour necrosis factor-α gene expression and production in human umbilical arterial endothelial cells
  Clinical Science, 2000
• Human vascular endothelial cells produce tumor necrosis factor-α in response to proinflammatory cytokine stimulation
  Critical Care Medicine, 1999
• Leukocyte-endothelial interaction is augmented by high glucose concentrations and hyperglycemia in a NF-kB-dependent fashion.
  Journal of Clinical Investigation, 1998
• Downregulation of Endothelial Constitutive Nitric Oxide Synthase Expression by Lipopolysaccharide
  Biochemical and Biophysical Research Communications, 1996
• Cellular receptors for advanced glycation end products. Implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions.
  Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994
• β2-Microglobulin Modified with Advanced Glycation End Products Induces Interleukin-6 from Human Macrophages: Role in the Pathogenesis of Hemodialysis-Associated Amyloidosis
  Biochemical and Biophysical Research Communications, 1994
• Possible role of tumor necrosis factor and interleukin-1 in the development of diabetic nephropathy
  Kidney International, 1991
• Role of Oxidative Stress in Development of Complications in Diabetes
  Diabetes, 1991
• Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells.
  Journal of Clinical Investigation, 1989
• Advanced Glycosylation End Products in Tissue and the Biochemical Basis of Diabetic Complications
  New England Journal of Medicine, 1988